DrugId:  1
1. Name:  Equus caballus dander
2. Groups:  Approved
3. Description:  Equus caballus dander is the dander of Equus caballus. Equus caballus dander is used in allergenic testing.
4. Indication:  Not Available
DrugId:  2
1. Name:  Cavia porcellus hair
2. Groups:  Approved
3. Description:  Guinea pig hair is used in allergenic testing.
4. Indication:  Not Available
DrugId:  3
1. Name:  Canis lupus familiaris dander
2. Groups:  Approved
3. Description:  Canis lupus familiaris dander is the dander of Canis lupus familiaris. Canis lupus familiaris dander is used in allergenic testing.
4. Indication:  Not Available
DrugId:  4
1. Name:  Bos taurus hair
2. Groups:  Approved
3. Description:  Bos taurus hair is used in allergenic testing.
4. Indication:  Not Available
DrugId:  5
1. Name:  Pyrimethamine
2. Groups:  Approved, Investigational, Vet approved
3. Description:  One of the folic acid antagonists that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis. [PubChem]
4. Indication:  For the treatment of toxoplasmosis and acute malaria; For the prevention of malaria in areas non-resistant to pyrimethamine
DrugId:  6
1. Name:  Equus caballus hair
2. Groups:  Approved
3. Description:  Horse hair is used in allergenic testing.
4. Indication:  Not Available
DrugId:  7
1. Name:  Bos taurus skin
2. Groups:  Approved
3. Description:  Bos taurus skin or pelt is used in allergenic testing.
4. Indication:  Not Available
DrugId:  8
1. Name:  Cavia porcellus skin
2. Groups:  Approved
3. Description:  Cavia porcellus skin or pelt is used in allergenic testing.
4. Indication:  Not Available
DrugId:  9
1. Name:  Egg white
2. Groups:  Approved
3. Description:  Egg white allergenic extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  10
1. Name:  Mesocricetus auratus skin
2. Groups:  Approved
3. Description:  Mesocricetus auratus skin or pelt is used in allergenic testing.
4. Indication:  Not Available
DrugId:  11
1. Name:  Rattus norvegicus skin
2. Groups:  Approved
3. Description:  Rattus norvegicus skin or pelt is used in allergenic testing.
4. Indication:  Not Available
DrugId:  12
1. Name:  Beef
2. Groups:  Approved
3. Description:  Beef allergenic extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  13
1. Name:  Egg yolk
2. Groups:  Approved
3. Description:  Egg yolk allergenic extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  14
1. Name:  Sus scrofa hair
2. Groups:  Approved
3. Description:  Wild boar hair is used in allergenic testing.
4. Indication:  Not Available
DrugId:  15
1. Name:  SD118
2. Groups:  Investigational
3. Description:  SD118 was previously under investigation in Japan for a different indication and now, following re-profiling and evaluation in experimental animal models, has demonstrated its potential as a new oral therapy for neuropathic pain.
4. Indication:  Central Nervous System - Neuropathic pain 
DrugId:  16
1. Name:  DNB-001
2. Groups:  Investigational
3. Description:  DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma. In preclinical animal models, DNB-001 has demonstrated potent IOP- lowering effects as well as neuroprotective effects on the optic nerve.
4. Indication:  Investigated for use/treatment in ocular hypertension.
DrugId:  17
1. Name:  Mus musculus skin
2. Groups:  Approved
3. Description:  Mus musculus skin or pelt is used in allergenic testing.
4. Indication:  Not Available
DrugId:  18
1. Name:  Meriones unguiculatus skin
2. Groups:  Approved
3. Description:  Meriones unguiculatus skin or pelt is used in allergenic testing.
4. Indication:  Not Available
DrugId:  19
1. Name:  Sulfisoxazole
2. Groups:  Approved, Vet approved
3. Description:  A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms. [PubChem]
4. Indication:  For the treatment of severe, repeated, or long-lasting urinary tract infections, meningococcal meningitis, acute otitis media, trachoma, inclusion conjunctivitis, nocardiosis, chancroid, toxoplasmosis, malaria and other bacterial infections.
DrugId:  20
1. Name:  Sulfadiazine
2. Groups:  Approved, Investigational, Vet approved
3. Description:  One of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections. [PubChem]
4. Indication:  For the treatment of rheumatic fever and meningococcal meningitis
DrugId:  21
1. Name:  Pork
2. Groups:  Approved
3. Description:  Pork allergenic extract is used in allergenic testing.
4. Indication:  Not Available
DrugId:  22
1. Name:  Capra hircus skin
2. Groups:  Approved
3. Description:  Capra hircus skin or pelt is used in allergenic testing.
4. Indication:  Not Available
DrugId:  23
1. Name:  Oryctolagus cuniculus hair
2. Groups:  Approved
3. Description:  European rabbit hair is used in allergenic testing.
4. Indication:  Not Available
DrugId:  24
1. Name:  JB991
2. Groups:  Investigational
3. Description:  JB991 is a cyclopentenone prostaglandin analogue intended for treatment of psoriasis. The drug exerts marked antiproliferative and pro-apoptotic effect in human keratinocytes and fibroblasts in vitro. In addition a closely related cyclopentenone prostaglandin analogue has been shown to exert marked anti-inflammatory effect in vivo in an animal model. The drug will be applied topically on the skin. 
4. Indication:  Investigated for use/treatment in psoriasis and psoriatic disorders and skin infections/disorders.
DrugId:  25
1. Name:  VSF-173
2. Groups:  Investigational
3. Description:  VSF-173 is an oral small molecule. It is an oral compound that has demonstrated effects on animal sleep/wake patterns and gene expression patterns suggestive of a stimulant effect. It is developed for the treatment of excessive sleepiness. Study shows that VSF-173 possesses a novel mechanism to address disorders of excessive sleepiness.
4. Indication:  Investigated for use/treatment in sleep disorders.
